Stryker Corporation
Stryker is a preeminent global medical technology company headquartered in Kalamazoo, Michigan, renowned for its strong commitment to research and innovation across orthopedics, neurotechnology, and surgical instruments. Founded in 1941 by orthopedic surgeon Dr. Homer Stryker, the company has consistently been one of the top orthopedic device companies by revenue, demonstrating a dedication to improving patient outcomes through advanced solutions. In the orthopedic devices sector, Stryker is a major market leader specializing in a comprehensive portfolio that includes hip, knee, shoulder, and trauma systems designed to restore mobility and quality of life. The company is particularly distinguished by its integration of advanced technology, most notably the Mako robotic-arm assisted surgery system. Mako is widely adopted in the US and globally for total knee, partial knee, total hip, and newly approved shoulder applications, transforming surgical precision and becoming a standard of care. Stryker also leverages surgical navigation and 3D printing technologies to expand its offerings and maintain its position at the forefront of orthopedic innovation.
Latest Market Research Report on Orthopedic Devices Download PDF Brochure Now
Johnson & Johnson – DePuy Synthes
DePuy Synthes operates as the orthopedic division of Johnson & Johnson MedTech, ranking among the world’s largest orthopedic device companies. With a rich history and significant global presence, the company is a leader in developing and marketing products for the surgical fixation, correction, and regeneration of the skeleton and related soft tissues, covering applications from the skull to the foot. DePuy Synthes offers comprehensive orthopedic solutions across joint reconstruction, trauma implants, spine systems, and sports medicine devices. It commands a high market share in key segments like orthopedic trauma, where it is known for pioneering technologies that enable minimally invasive procedures and advanced implant designs. The company actively invests in R&D, combining cutting-edge biomaterials with digital surgery tools to optimize orthopedic interventions and meet evolving clinical needs. Its extensive portfolio and backing by Johnson & Johnson’s resources cement its role as a core contributor to transforming musculoskeletal health globally.
Zimmer Biomet Holdings, Inc.
Zimmer Biomet is a globally leading medical device company specializing in orthopedic reconstruction and musculoskeletal healthcare, based in Warsaw, Indiana—often called the “Orthopedic Capital of the World.” Formed by the merger of Zimmer and Biomet, the company is dedicated to improving the quality of life for patients through innovation. Zimmer Biomet manufactures an extensive range of products, including joint implants for the hip, knee, shoulder, and extremities, as well as surgical instruments and bone healing technologies. A key area of technological focus is digital health and robotics, exemplified by the ROSA robotic system used for knee, hip, and recently approved shoulder replacement surgeries. Furthermore, Zimmer Biomet maintains a strong presence in the orthopedic biomaterials market, offering the broadest range of products in the bone growth stimulator segment, including internally implanted devices. The company’s strategy involves leveraging data analytics and digital platforms to create personalized and efficient surgical workflows worldwide.
Medtronic PLC
Medtronic PLC is a global leader in healthcare solutions, with a significant and influential division dedicated to orthopedic and spinal devices. Headquartered in Dublin, Ireland, Medtronic’s focus within orthopedics is primarily on the high-growth spine market, where it holds the largest market share globally. The company provides a broad range of advanced solutions for spine surgery, including specialized biologics and bone grafting materials. Medtronic is committed to leveraging advanced technology to enhance surgical precision, actively integrating robotics, navigation systems, and AI-driven technologies into its platforms, such as the Mazor system for spinal procedures. This focus allows Medtronic to specialize in minimally invasive procedures, improving patient outcomes, and significantly reducing recovery times, thereby playing a vital role in advancing the future of musculoskeletal treatment across the globe.
Smith + Nephew PLC
Smith + Nephew is a prominent multinational medical technology company based in the UK, specializing in providing advanced products for orthopedics, sports medicine, and wound management. Within the orthopedic sector, the company is a leading player with wide product coverage across the knee, hip, and shoulder segments. Smith + Nephew is renowned for its strength in sports medicine and arthroscopy, where it offers a variety of products including the DYONICS™ EFLEX™ radiofrequency probe, a market leader in hip arthroscopy. In the joint replacement market, they have invested heavily in robotics with the launch of the CORI surgical system, a handheld robotic solution utilized for both knee and total hip implants. The company’s overall strategy is centered on technological innovation and digital integration, helping surgeons perform complex procedures more efficiently and improving patient mobility.
Arthrex
Arthrex is an innovative, privately held medical device company that has achieved market dominance in the field of orthopedic soft tissue repair and reconstruction, holding nearly 43% of that market share. The company operates under the mission “Helping Surgeons Treat Their Patients Better” by pioneering new surgical techniques and developing corresponding advanced products. Based in Naples, Florida, Arthrex specializes heavily in sports medicine injuries and orthopedic conditions. Notable innovations include the Achilles Midsubstance SpeedBridge™ system and the revolutionary FiberTape® Cerclage Technique, which offers a strong, low-profile alternative to traditional metal cables and wires for fracture management. Arthrex’s commitment to scientific research, with thousands of peer-reviewed publications and active studies, drives the continuous advancement of its orthobiologics, such as the ArthroCell™ Bone Allograft, reinforcing its reputation as a leader in specialized orthopedic solutions.
Globus Medical
Globus Medical is a major force in the musculoskeletal solutions market, particularly in spine technology, following its significant merger with NuVasive. This strategic integration positioned Globus Medical as one of the top four companies dominating the worldwide spine market. The company is dedicated to developing innovative products and surgical solutions that address musculoskeletal conditions. Its primary contribution to the orthopedic device landscape is its advancement in robotic technology for spine surgery, featuring the highly utilized Excelsius system. Globus Medical’s focus is on providing integrated solutions that enhance surgical efficiency, precision, and patient outcomes in complex spinal procedures. The company’s continued investment in cutting-edge technology ensures it remains a leader in advancing the use of robotics within the orthopedic surgical environment.
Enovis
Enovis is a focused medical technology company committed to developing clinically differentiated therapeutic solutions designed to generate measurably better patient outcomes and transform clinical workflows. The company encompasses a broad range of products, including its strong Regeneration portfolio which features bone growth stimulators like Spinalogic® and Manafuse®, aimed at improving healing for orthopedic and spine patients. Enovis also includes leading brands such as DonJoy and Aircast for bracing and support, and Enovis Surgical for hip and shoulder replacement solutions. The company emphasizes a culture of continuous improvement, leveraging its extensive range of products, services, and integrated technologies to partner with healthcare professionals. With a global footprint and a mission of “Creating Better Together,” Enovis is focused on transforming patient care and enabling active lifestyles through its diverse orthopedic and rehabilitation offerings.
MicroPort Orthopedics
MicroPort Orthopedics, a key subsidiary of MicroPort Scientific Corporation, is a focused orthopedic company committed to improving patient outcomes through its specialization in joint reconstruction, particularly in hip and knee replacement systems. The company distinguishes itself with a focus on proprietary, tissue-sparing approaches for total hip replacement designed to reduce the length of hospital stay. Its flagship product is the Evolution® medial-pivot knee system, which is backed by years of clinical excellence and designed to optimize stability and allow patients to return to function faster. MicroPort Orthopedics actively collaborates to integrate digital technology, such as the Pixee Medical Knee+ platform, into its surgical offerings. By continually leveraging extensive orthopedic experience and superior clinical results, MicroPort Orthopedics maintains its position as an important global distributor of innovative, high-performance orthopedic devices.
Orthofix
Orthofix is a specialized global medical device company that significantly enhanced its presence in the spine and orthopedics market following its merger with SeaSpine in early 2023. The company is dedicated to delivering innovative, evidence-based solutions for patients requiring musculoskeletal treatment and recovery. Orthofix’s core offerings include a broad range of spinal implant systems, specialized biologics, and devices for bone fracture treatment and healing. By focusing on both surgical solutions and recovery products like bone growth stimulators, Orthofix plays a critical role across the continuum of orthopedic care. The company’s commitment to advancing technologies and providing comprehensive systems allows surgeons to address complex orthopedic challenges, ensuring its continued relevance in the competitive global market for orthopedic devices.
Latest Market Research Report on Orthopedic Devices Download PDF Brochure Now